LT - Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas
EN - Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 51/04 |
|
|
|
A61P 35/00 |
|
|
|
A61K 101/02 |
|
European patent
(11) |
Number of the document |
2044961 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
08020805.1 |
|
Date of filing the European patent application |
2005-03-02 |
(97) |
Date of publication of the European application |
2009-04-08 |
(45) |
Date of publication and mention of the grant of the patent |
2013-07-17
|
(46) |
Date of publication of the claims translation |
|
Priority applications
(30) |
Number |
Date |
Country code |
|
521166 P |
2004-03-02
|
US |
Inventors
(72) |
Weichert, Jamey, US
Longino, Marc, US
Pinchuk, Anatoly, US
|
Grantee
(73) |
Cellectar, Inc.,
3301 Agriculture Drive, Madison, WI 53716,
US
|
Title
(54) |
Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas |
|
Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas |